Business20 Oct 2026
OpenAI acquires Orchestra Bio for its Rosalind life-sciences unit
OpenAI bought Orchestra Bio, whose AI agents keep drug programmes on schedule, and is folding the team into its Rosalind life-sciences push; terms were not disclosed.
